- |||||||||| Trial completion, Combination therapy, Metastases: Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer (clinicaltrials.gov) - Jun 10, 2013
P1, N=16, Completed, N=188 --> 492 Active, not recruiting --> Completed
- |||||||||| Neupogen (filgrastim) / Kyowa Kirin, Amgen
Enrollment closed, IO biomarker, Surgery: acns0333: Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System (clinicaltrials.gov) - Jun 9, 2013 P3, N=70, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- |||||||||| Erbitux (cetuximab) / Eli Lilly
New P2 trial, Metastases: Nordic 8 - A Phase II Trial (clinicaltrials.gov) - Jun 2, 2013 P2, N=180, Recruiting,
|